CNR1 and pulmonary fibrosis: Pulmonary fibrosis is a group of lethal disease characterized by deposition of a pathological ECM, we further evaluated the efficacy of CB1R-selective agonist ACPA on collagen deposition and the expression of fibrotic makers in BLM-induced experimental pulmonary fibrosis in vivo (Figure 2).